NEWS: Envisia Genomic Classifier Highlighted in Updated Clinical Guidelines for IPF Diagnosis Learn More
NEWS: Envisia Genomic Classifier Highlighted in Updated Clinical Guidelines for IPF Diagnosis Learn More
Skip to content
INFORMATION REQUESTS

INFORMATION REQUESTS

Investor & Media Contact:
Tracy Morris
tracy.morris@veracyte.com
650-380-4413
 

Please submit your question using the form below.

* Indicates required field
Contact Information
 
Investors:
investors@veracyte.com
619.393.1545
 
Media:
Tracy Morris
tracy.morris@veracyte.com
650.380.4413
Disclaimer
 

The information in our press releases and webcasts should be considered accurate only as of the date of the press release or presentation. We disclaim any obligation to supplement or update the information in these press releases or presentations.